Analysis of 21 patients of chronic kidney disease complicated with pneumocystis pneumonia
- VernacularTitle:慢性肾脏疾病并发肺孢子菌肺炎21例分析
- Author:
Wenling YE
;
Yang YU
;
Hang LI
;
Limeng CHEN
;
Ruitong GAO
;
Mingxi LI
;
Dongyan LIU
;
Xuejun ZENG
;
Jinglan WANG
;
Hui WANG
;
Xuemei LI
;
Xuewang LI
- Publication Type:Journal Article
- Keywords:
Kidney disease;
Pneumocystis pneumonia;
Opportunistic infection
- From:
Chinese Journal of Nephrology
2008;24(8):555-559
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical features of pneumocystis pneumonia (PCP) in patients with chronic kidney disease. Methods Clinial data of 21 cases of the primary and secondary kidney diseases complicated with PCP,excluding renal transplantation,were analyzed retrospectively. Results Twenty-one cases consisted of 6 cases of primary renal diseases and 15 eases of secondary renal diseases.Twenty patients (95.2%) were receiving immunesuppressive therapy at the PCP onset.Main manifestations were fever,progressive dyspnea,cough with no or seldom sputum.Twenty patients presented obvious hypoxemia and 12 of them were type I respiratory failure.X-ray and CT imaging of 20 patients revealed diffuse pulmonary interstitial shadows or ground glass opacities in both lungs.All the patients were treaed with trimethoprim-sulfamethoxazole.Eleven patients died accounting for 52.3%.Compared with the survivors,elder age (60.91±15.08 vs 44.50±14.83,P＜0.05),lower blood oxygen pressure at onset [(48.11±19.05)mm Hg vs (65.91±13.13)mm Hg,P＜0.01],higher percentage of respirator application and other secondary lung infection were found in dead patients.No PCP relapsed after average 16-month follow-up in the survival patients. Conclusions PCP is a severe complication with high mortality during immunosuppressive therapy in patients with chronic renal disease.Early diagnosis and proper treatment are important to improve prognosis.
